Newly published research from Chris Bojke and co-authors estimates productivity growth in the NHS from 1998/1999 to 2013/2014. Total output of the NHS comprises both the volume of various services and their quality while inputs… Read More »You won’t believe what these NHS productivity statistics mean for health policy!
Efficiency and Equity
Welfare, efficiency, equity and possible conflicts; inequal-
ity and the socio-economic ‘gradient’; evaluating efficiency at system level: international comparisons in the developed world; techniques for measuring equity and inequity; evaluat- ing equity at system level: equity in financing arrangements; evaluating equity at system level: equity in service access and delivery; evaluating equity at system level: equity in the dis- tribution of health; institutional arrangements for efficiency and equity; implications for health care financing and delivery systems in the developed world; centralization and decentral- ization in health care; the role and regulation of markets in developed countries.
The cost-effectiveness threshold utilised by health technology assessment agencies, such as NICE in the United Kingdom, below which new medical technologies and interventions are considered cost-effective, is frequently discussed. NICE currently use a threshold of… Read More »Do we really need to change the cost-effectiveness threshold?
NICE recently completed their appraisal of the hepatitis C drug sofosbuvir. However, as has been reported in the media, NHS England will not be complying with the guidance within the normal time period. The cost of a 24 week… Read More »Sofosbuvir: a fork in the road for NICE?